- Home
- SKYE vs COE Comparison
SKYE vs COE Comparison
Compare SKYE & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- COE
- Stock Information
- Founded
- SKYE 2012
- COE 2011
- Country
- SKYE United States
- COE Singapore
- Employees
- SKYE N/A
- COE N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- COE Other Consumer Services
- Sector
- SKYE Health Care
- COE Real Estate
- Exchange
- SKYE Nasdaq
- COE Nasdaq
- Market Cap
- SKYE 108.3M
- COE 91.5M
- IPO Year
- SKYE N/A
- COE 2016
- Fundamental
- Price
- SKYE $4.12
- COE $14.92
- Analyst Decision
- SKYE Buy
- COE
- Analyst Count
- SKYE 6
- COE 0
- Target Price
- SKYE $18.67
- COE N/A
- AVG Volume (30 Days)
- SKYE 166.3K
- COE 3.6K
- Earning Date
- SKYE 11-07-2024
- COE 12-16-2024
- Dividend Yield
- SKYE N/A
- COE N/A
- EPS Growth
- SKYE N/A
- COE N/A
- EPS
- SKYE N/A
- COE N/A
- Revenue
- SKYE N/A
- COE $35,705,000.00
- Revenue This Year
- SKYE N/A
- COE N/A
- Revenue Next Year
- SKYE N/A
- COE N/A
- P/E Ratio
- SKYE N/A
- COE N/A
- Revenue Growth
- SKYE N/A
- COE 66.41
- 52 Week Low
- SKYE $1.44
- COE $6.00
- 52 Week High
- SKYE $19.41
- COE $19.75
- Technical
- Relative Strength Index (RSI)
- SKYE 35.19
- COE 47.80
- Support Level
- SKYE $4.32
- COE $14.00
- Resistance Level
- SKYE $5.67
- COE $15.53
- Average True Range (ATR)
- SKYE 0.49
- COE 0.81
- MACD
- SKYE -0.17
- COE -0.01
- Stochastic Oscillator
- SKYE 2.65
- COE 46.00
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand.